Business Context and Reporting Period
Company: Personalis, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 28, 2025
Event: Filing of a prospectus supplement under an existing shelf registration statement (Form S-3, No. 333-276204).
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document is a procedural report regarding a securities offering.
Material Changes
The Company filed a prospectus supplement relating to the offer and sale of up to $100,000,000 of shares of its common stock. This offering is conducted pursuant to an Amended and Restated At-the-Market Sales Agreement dated December 27, 2024, with Piper Sandler & Co. and BTIG, LLC. This supplement is in addition to the Company's existing offering of common stock under the sales agreement prospectus dated December 27, 2024.
Guidance, Outlook, and Risks
The filing does not provide management commentary, financial guidance, or specific risk factors beyond the standard disclosure of the securities offering. The document includes an opinion of counsel (Cooley LLP) regarding the shares offered.
Investor Verification Checklist
- Verify the terms of the Amended and Restated At-the-Market Sales Agreement dated December 27, 2024.
- Confirm the total number of shares previously sold under the existing sales agreement to assess remaining capacity.
- Review the full Prospectus Supplement for specific pricing mechanisms and underwriting fees.
- Check recent 10-Q or 10-K filings for the Company's current cash position and liquidity needs driving this offering.